» Articles » PMID: 17262956

[Preparation of Huperzine A Nasal in Situ Gel and Evaluation of Its Brain Targeting Following Intranasal Administration]

Overview
Journal Yao Xue Xue Bao
Specialties Pharmacology
Pharmacy
Date 2007 Feb 1
PMID 17262956
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The feasibility of intranasal brain targeting drug delivery system via the olfactory pathway from nose to brain was explored.

Methods: Using gellan gum, a cation-sensitive gel forming excipient, huperzine A (Hup A) nasal in situ gel was prepared by pH gradient precipitation method. The pharmacokinetics of Hup A in blood and cerebrospinal fluid (CSF) after intranasal, intravenous and intragastric adminstration to rats was studied using cisternal cannulation for serial CSF sampling and femoral artery cannulation for serial blood sampling. The distributions of Hup A into rat brain tissues following intranasal dosing were compared with those after intravenous and intragastric dosing by tissue homogeneization. The therapeutics effects of Hup A nasal in situ gel on cognitive function were tested in mice and rats with Morris water maze, step down test and step through test.

Results: The AUC(0-->6 h) value in plasma obtained after nasal administration was 0.94 of that after intravenous administration, but the AUC(0-->6 h) of CSF after nasal administration was 1.3 and 2.3 times of that after intravenous and intragastric administration. The AUC(0-->6 h), of cerebrum, hippocampus, cerebellum, left olfactory bulb and right olfactory bulb after nasal administration were 1.5, 1.3, 1.0, 1.2 and 1.0 of that after intravenous administration, 2.7, 2.2, 1.9, 3.1 and 2.6 times of that after intragastric administration, respectively. Intranasal adminintration of 17.5-35 microg x kg(-1) showed equal effects after oral adminintration of 70 microg x kg(-1) commercial tablets, which was in good agreement with the results of pharmacokinetics.

Conclusion: Intranasal administration of huperzine A nasal in situ gel significantly increased the distributions of Hup A into rat brain tissues, especially into cerebrum and hippocampus which should be the target areas of Hup A, and enhanced the brain targeting of Hup A.

Citing Articles

Recent opportunities and application of gellan gum based drug delivery system for intranasal route.

Garg A, Lavania K Daru. 2024; 32(2):947-965.

PMID: 39361194 PMC: 11555193. DOI: 10.1007/s40199-024-00543-w.


Investigation of the "Nose-to-Brain" Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability.

Jiang Y, Jiang Y, Ding Z, Yu Q Int J Nanomedicine. 2022; 17:3443-3456.

PMID: 35959279 PMC: 9359405. DOI: 10.2147/IJN.S369978.


In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases.

Aderibigbe B Pharmaceutics. 2018; 10(2).

PMID: 29601486 PMC: 6027251. DOI: 10.3390/pharmaceutics10020040.


Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.

Meng Q, Wang A, Hua H, Jiang Y, Wang Y, Mu H Int J Nanomedicine. 2018; 13:705-718.

PMID: 29440896 PMC: 5798568. DOI: 10.2147/IJN.S151474.


Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin.

Cai Z, Song X, Sun F, Yang Z, Hou S, Liu Z AAPS PharmSciTech. 2011; 12(4):1102-9.

PMID: 21879392 PMC: 3225523. DOI: 10.1208/s12249-011-9678-y.